Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary hypertension and fenfluramine.

H M Pouwels1, J L Smeets, E C Cheriex

  • 1Dept of Pulmonary Diseases, University Hospital Maastricht, The Netherlands.

The European Respiratory Journal
|May 1, 1990
PubMed
Summary

Fenfluramine, an obesity drug, can rarely cause pulmonary hypertension. This condition resolved in a patient after discontinuing fenfluramine treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between lung function and dyspnoea and its variation in the multinational Burden of Obstructive Lung Disease (BOLD) study.

Pulmonology·2024
Same author

Idiopathic atrial fibrillation patients rapidly outgrow their low thromboembolic risk: a 10-year follow-up study.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2019
Same author

Multidisciplinary decision-making in mitral valve disease: the mitral valve heart team.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2019
Same author

Dizziness and slow heart rate during exercise.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2017
Same author

Dizziness and slow heart rate during exercise.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2017
Same author

Typical ECG findings in an unconscious patient.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2016

Area of Science:

  • Cardiology
  • Pharmacology
  • Pulmonology

Background:

  • Fenfluramine is a prescription anorectic agent used as an adjuvant therapy for obesity management.
  • While effective for weight loss, rare adverse effects on the cardiovascular system are a concern.

Observation:

  • A case study involving a patient treated with fenfluramine for obesity is presented.
  • The patient developed severe pulmonary hypertension and subsequent right heart failure during treatment.

Findings:

  • Pulmonary hypertension is a rare but serious potential adverse effect of fenfluramine therapy.
  • The patient's pulmonary hypertension and right heart failure symptoms significantly improved after fenfluramine withdrawal.

Implications:

  • This case highlights the importance of monitoring for cardiovascular complications in patients using fenfluramine.
  • Discontinuation of fenfluramine may lead to the resolution of drug-induced pulmonary hypertension.
  • Further research into the mechanisms and incidence of fenfluramine-associated pulmonary hypertension is warranted.

Related Experiment Videos